Browse > Article
http://dx.doi.org/10.3746/jkfn.2011.40.5.704

90-day Repeated-dose Oral Toxicity Study of 20 kGy Irradiated Cold Water Extract Powder of Mistletoe  

Kim, Jin-Kyung (Dept. of Medical Life Science, Catholic University of Daegu)
Jeon, Young-Eun (Dept. of Food Science and Nutrition & The Korean Institute of Nutrition, Hallym University)
Yin, Xing Fu (Dept. of Food Science and Nutrition & The Korean Institute of Nutrition, Hallym University)
Lee, Ju-Woon (Division of Radiation Application Research, Korea Atomic Energy Research Institute)
Kang, Il-Jun (Dept. of Food Science and Nutrition & The Korean Institute of Nutrition, Hallym University)
Publication Information
Journal of the Korean Society of Food Science and Nutrition / v.40, no.5, 2011 , pp. 704-711 More about this Journal
Abstract
Traditionally, mistletoes have been used as immunostimulant for the management of certain diseases such as cancer with high profile immune depleting potentials. In order to examine the safety of the 20 kGy irradiated cold water extract powder of mistletoes, we performed a 90-day repeated-dose toxicity study with ICR mice. The mice were treated with daily doses of the 20 kGy irradiated cold water extract powder of mistletoes by gavage at 0, 20, 100, and 500 mg/kg/day for 90 consecutive days. We recorded clinical signs of toxicity, body weight, organ weights, histological changes in target organs, hematology, and clinical blood chemistry analysis data for all mice. There were no significant changes in body and organ weights during the experimental period. The hematological analysis and clinical blood chemistry data revealed no toxic effects from the 20 kGy irradiated cold water extract powder of mistletoes. Pathologically, neither gross abnormalities nor histopathological changes were observed between the control and treated mice of both sexes. Collectively, these data suggest that the 20 kGy irradiated cold water extract powder of mistletoes have a high margin of safety.
Keywords
mistletoes; gamma irradiation; 90-day repeated-dose oral toxity;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
Times Cited By SCOPUS : 0
연도 인용수 순위
1 Bussing A. 1997. Mistletoe: a story with an open end. Anti-Cancer Drug 8(suppl 1): S1-S2.
2 Rentea R, Lyon E, Hunter R. 1981. Biologic properties of iscador: a Viscum album preparation: I. Hyperplasia of the thymic cortex and accelerated regeneration of hematopoietic cells following x-irradiation. Lab Invest 44: 43-48.
3 Walzel H, Mix E, Jenssen HL, Ziska P, Franz H. 1982. Estimation of toxicity of the mistletoe lectin 1 using the footpad swelling test in mice. Acta Histochem 71: 41-42.   DOI   ScienceOn
4 Stein GM, Pfuller U, Schietzel M, Bussing A. 2000. Toxic proteins from European mistletoe (Viscum album L.): increase of intracellular IL-4 but decrease of IFN-gamma in apoptotic cells. Anticancer Res 20: 1673-1678.
5 Gossrau R, Franz H. 1990. Histochemical response of mice to mistletoe lectin I (ML I). Histochemistry 94: 531-537.   DOI
6 Wolford ST, Schroer RA, Gohs FX, Gallo PP, Brodec M, Falk HB, Ruhren FR. 1986. Reference range data base for serum chemistry and hematology values in laboratory animals. J Toxicol Environ Health 18: 161-188.   DOI
7 Park CH, Park CG, Bang KH, Park HW, Seong NS. 2003. Plant growth and anatomical characteristics of Korean mistel (Viscum album var. coloratum (kom.) Ohwi). Korean J Med Crop Sci 11: 122-126.   과학기술학회마을
8 Kuttan G, Kuttan R. 1992. Immunomodulatory activity of a peptide isolated from Viscum album extract (NSC 635 089). Immunol Invest 21: 285-296.   DOI
9 Hajto T, Hostanska K, Frei K, Rordorf C, Gabius HJ. 1990. Increased secretion of tumor necrosis factor $\alpha$, interleukin 1, and interleukin 6 by human mononuclear cells exposed to $\beta$-galactoside-specific lectin from clinically applied mistletoe extract. Cancer Res 50: 3322-3326.
10 Bussing A, Suzart K, Schweizer K. 1997. Differences in the apoptosis-inducing properties of Viscum album L. extracts. Anti-Cancer Drug 8(suppl 1): S9-S14.   DOI
11 Habeck M. 2003. Mistletoe compound enters clinical trials. Drug Discov Today 8: 52-53.   DOI
12 Bauer C, Oppel T, Rueff F, Przybilla B. 2005. Anaphylaxis to viscotoxins of mistletoe (Viscum album) extracts. Ann Allergy Asthma Immunol 94: 86-89.   DOI
13 Lyu SY, Park SM, Choung BY, Park WB. 2000. Comparative study of Korean (Viscum album var. coloratum) and European mistletoes (Viscum album). Arch Pharm Res 23: 592-598.   과학기술학회마을   DOI
14 Jung MJ, Yoo YC, Lee KB, Kim JB, Song KS. 2004. Isolation of epi-oleanolic acid from Korean mistletoe and its apoptosis-inducing activity in tumor cells. Arch Pharm Res 27: 840-844.   과학기술학회마을   DOI
15 Khwaja TA, Dias CB, Pentecost S. 1986. Recent studies on the anticancer activities of mistletoe (Viscum album) and its alkaloids. Oncology 43(suppl 1): 42-50.   DOI